Home | About FPMPAM | FPMPAM Committee | From The President | In The News | Events | Outreach Programmes | Newsletter | Affiliates
2014 Federation of Private Medical Practitioners’ Associations, Malaysia
12.7.2024, Kuala Lumpur
The Federation of Private Medical Practitioners Associations Malaysia (FPMPAM) supports the Academy of Family Physicians of Malaysia (AFPM) on in its call to make amendments to the Medical Act 1971 (Act 50) to resolve the issue of registering medical doctors who obtain their specialist qualifications through the parallel pathway and to streamline the process of recognition and registration as medical specialists.
In the face of much opposition, it is our hope that Health Minister, Datuk Seri Dr Dzulkefly Ahmad, has the gumption to do what is right in addressing the ongoing issues surrounding the parallel pathway specialist training.
The local Masters programme has not been able to cope in producing specialists in tandem with the national demand. The parallel pathway training programme can alleviate this vacuum of insufficient specialists, in order to reduce waiting times for critical care, and support programmes that can fast track training.
Such combination of the various pathways can only benefit the country, and it is common sense that these pathways be appropriately recognised, encouraged and set in the appropriate legal framework. Attempts to monopolise post graduate training must be frowned upon.
Further, we support the AFPM desire to review the composition of elected and appointed members of the Malaysian Medical Council as there is disproportionate numbers of university representatives in the current structure of the council, and a glaring under-representation of private medical practitioners to the Council.

Dr Shanmuganathan Ganesan.
President, FPMPAM
12 July 2024

8th FPMPAM/IPH ASM 2026 incorporating 14th NatCAM
Details >>
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>
Joint Integrated Healthcare Committee (JIHC) Term Sheet
Click here >>
Joint Integrated Healthcare Committee (JIHC) Terms of Reference
Click here >>
National Pharmaceutical Regulatory Agency
Click here >>
NPRA: Reporting medicinal problems
Click here >>
Makluman Kontraindikasi Penggunaan Ubat Yang Mengandungi Codeine Untuk Kanak-Kanak Beumur Bawah 12 Tahun Dan Ibu Yang Menyusu Susulan Risiko Respiratory Depression
Click here >>
Peringatan: Langkah-Langkah Pengurangan Risiko Bagi Kesan Advers Kulit Tang Serius Susulan Penggunaan Allopurinol
Click here >>
VALPROATE
Guide for HCP >>
Patient Information >>
Sodium Valproate (Guide for HCP) >>
NDST Report 2011
Click here >>
Garis Panduan Pemantauan Keselamatan Produk ESAs dan Pelaporan Kesan Advers PRCA
Click here >>
Report On Suspected Adverse Drug Reactions
Click here >>
MADRAC Newsletter Vol 26 Issue 2 / 2018
Read >>
MADRAC KE 146 - Traditional Medicine found Adulterated
Read >>
BPFK website: Cancellation of Registered Traditional Products / Notified Cosmetics
Read >>
Pharmacy Services Division: List of Adulterated Products
Read >>
Pharmacy Services Division: Press Releases
Read >>